NCT05204030

Brief Summary

Parents use social media as an important parenting tool and source for health information. Using social media data to examine public opinion has had an early impact in public health and in cancer control and prevention efforts, including about the human papillomavirus (HPV) vaccine. A next step in this area of research is to develop and share messages on social media with parents to help inform and educate them about the HPV vaccine - ultimately assisting them with their decision to vaccinate their child. This study will evaluate the efficacy of social media messages through Twitter, using a randomized controlled trial to determine what types of messages resonate with parents. The investigators will examine differences between two types of messages - narrative messages (i.e., stories) and non-narrative messages (i.e., numbers and facts).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 9, 2021

Completed
4 days until next milestone

Study Start

First participant enrolled

December 13, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 24, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2023

Completed
Last Updated

January 30, 2023

Status Verified

January 1, 2023

Enrollment Period

1.7 years

First QC Date

December 9, 2021

Last Update Submit

January 26, 2023

Conditions

Keywords

Human Papilloma VirusHuman Papilloma Virus VaccineHuman Papilloma Virus VaccinationInterventionSocial mediaTwitterParentsChild healthCancer preventionVaccine acceptanceNarrative engagementPatient self-reportIntention to vaccinatecommunity engagementPublic HealthVaccination

Outcome Measures

Primary Outcomes (2)

  • Change in caregiver self-reported HPV vaccination status of child questionnaire

    dependent variable; measure collects date of vaccination and number of vaccine doses to date

    Change in caregiver self-reported HPV vaccination of child at 1-month follow-up from baseline

  • Change in caregiver self-reported HPV vaccination status of child questionnaire

    dependent variable; measure collects date of vaccination and number of vaccine doses to date

    Change in caregiver self-reported HPV vaccination of child at 1-year follow-up from 1-month follow-up

Secondary Outcomes (5)

  • Caregiver self-reported empathy subscale adapted from Busselle & Bilandzic (2009) and Murphy, Frank, Chatterjee, Baezconde-Garbanati (2013).

    only at 1-month post intervention

  • Caregiver self-reported transportation subscale adapted from Murphy, Frank, Chatterjee, Baezconde-Garbanati (2013). Narrative versus Non-narrative: The Role of Identification, Transportation and Emotion in Reducing Health Disparities.

    only at 1-month post intervention

  • Caregiver self-reported identification subscale adapted from Murphy, Frank, Chatterjee, Baezconde-Garbanati (2013). Narrative versus Non-narrative: The Role of Identification, Transportation and Emotion in Reducing Health Disparities.

    only at 1-month post intervention

  • Change in caregiver self-reported intention to vaccinate their child questionnaire

    Change in caregiver self-reported intention to vaccinate their child at 1-month follow-up from baseline

  • Change in caregiver self-reported intention to vaccinate their child questionnaire

    Change in caregiver self-reported intention to vaccinate their child at 1-year follow-up from 1-month follow-up

Study Arms (2)

Narrative

EXPERIMENTAL

The intervention condition will present narrative-focused messages about HPV and the HPV vaccine that includes important parent focused exemplar language and cultural norms on Twitter told through stories and characters (i.e., pseudo-parents).

Other: HPV Twitter Education Program - Narrative

Non-Narrative

ACTIVE COMPARATOR

The non-narrative condition will present scientific-focused messages about HPV and the HPV vaccine that includes important information relayed with numbers and facts.

Other: HPV Twitter Education Program - Non-Narrative

Interventions

This study will evaluate the efficacy of social media messages through Twitter, using a randomized controlled trial to determine what types of messages resonate with parents. The investigators will examine narrative messages (i.e., stories). The central hypothesis is that parents who read narrative-focused messages will be more likely to report narrative engagement, intention to vaccinate their child, and self-reported vaccination compared to parents who read non-narrative messages.

Narrative

This study will evaluate the efficacy of social media messages through Twitter, using a randomized controlled trial to determine what types of messages resonate with parents. The investigators will examine non-narrative messages (i.e., scientific information - numbers and facts). The central hypothesis is that parents who read narrative-focused messages will be more likely to report narrative engagement, intention to vaccinate their child, and self-reported vaccination compared to parents who read non-narrative messages.

Non-Narrative

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults 18 years of age and older;
  • Utilizes Twitter, a social media platform;
  • Has a child aged 9-14;
  • Child has not started the 2-dose HPV vaccination series;
  • Has no child who has completed any dose HPV vaccination series;
  • Has a well-care visit scheduled for their child before December, 2022.

You may not qualify if:

  • Any adult who does not have a child 9-14 years of age;
  • Any adult who does not indicate some level of participation in Twitter;
  • Any adults who indicates a high level of anti-vaccine sentiment (assessed by vaccine hesitancy questions asked in the screener).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Arkansas

Fayetteville, Arkansas, 72701, United States

Location

Related Publications (3)

  • Massey PM, Kearney MD, Hauer MK, Selvan P, Koku E, Leader AE. Dimensions of Misinformation About the HPV Vaccine on Instagram: Content and Network Analysis of Social Media Characteristics. J Med Internet Res. 2020 Dec 3;22(12):e21451. doi: 10.2196/21451.

    PMID: 33270038BACKGROUND
  • Massey PM, Togo E, Chiang SC, Klassen AC, Rose M, Manganello JA, Leader AE. Identifying HPV vaccine narrative communication needs among parents on social media. Prev Med Rep. 2021 Jul 7;23:101488. doi: 10.1016/j.pmedr.2021.101488. eCollection 2021 Sep.

    PMID: 34295614BACKGROUND
  • Massey PM, Chiang SC, Rose M, Murray RM, Rockett M, Togo E, Klassen AC, Manganello JA, Leader AE. Development of Personas to Communicate Narrative-Based Information About the HPV Vaccine on Twitter. Front Digit Health. 2021 Aug 4;3:682639. doi: 10.3389/fdgth.2021.682639. eCollection 2021.

    PMID: 34713151BACKGROUND

MeSH Terms

Conditions

Vaccine-Preventable Diseases

Condition Hierarchy (Ancestors)

Infections

Study Officials

  • Philip M Massey, PhD, MPH

    University of California, Los Angeles

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This 4-year study will evaluate the efficacy of a Twitter-based pilot intervention through a randomized controlled trial that will enroll a total of 600 parents/caregivers of children ages 9-14, whose child(ren) has not started the vaccine series. The intervention will consist of 2 arms and 12 monthly cohorts. After enrollment in the project, 300 participants will be randomized into the intervention arm and 300 participants will be enrolled into the control arm. Participants will be presented the intervention one month before their child's next wellcare visit.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2021

First Posted

January 24, 2022

Study Start

December 13, 2021

Primary Completion

August 30, 2023

Study Completion

August 30, 2023

Last Updated

January 30, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

There is not a plan to make IPD available.

Locations